CD276 and cancer: At last, development of suitable models for cancer modeling such as spheroids and organoids that will provide more information about the therapeutic potential of targeting B7-H3 alone and in combination with existing therapies (e.g. radio-, chemo- and immuno-therapy) will accelerate its translation into real clinical settings.